Gene Symbol | Gene ID | Gene Info |
---|---|---|
Glis2
|
ENSMUSG00000014303.7 | GLIS family zinc finger 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_4586338_4587480 | Glis2 | 7804 | 0.126187 | -0.82 | 1.5e-14 | Click! |
chr16_4596088_4596431 | Glis2 | 1546 | 0.276938 | 0.66 | 5.5e-08 | Click! |
chr16_4594874_4595091 | Glis2 | 269 | 0.866560 | 0.59 | 2.5e-06 | Click! |
chr16_4595091_4596084 | Glis2 | 874 | 0.473690 | 0.56 | 7.5e-06 | Click! |
chr16_4598925_4599076 | Glis2 | 2163 | 0.205795 | 0.54 | 2.4e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_124439906_124440949 | 60.65 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr12_3236518_3237725 | 43.13 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_3948585_3949537 | 23.40 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr14_4649279_4649596 | 19.89 |
Gm3239 |
predicted gene 3239 |
14755 |
0.11 |
chr14_5000842_5001422 | 19.52 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr14_7488846_7489218 | 18.65 |
Gm3752 |
predicted gene 3752 |
5270 |
0.15 |
chr14_6037512_6038662 | 18.23 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr14_4110111_4111235 | 18.19 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr2_107125684_107125835 | 17.95 |
Gm13903 |
predicted gene 13903 |
1799 |
0.38 |
chr10_26078964_26079158 | 17.55 |
Tmem200a |
transmembrane protein 200A |
9 |
0.95 |
chr14_4018192_4019443 | 17.52 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr14_7244047_7245236 | 17.38 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr10_81559146_81561402 | 16.98 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr19_61225302_61226760 | 16.46 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr16_43503682_43504014 | 16.13 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
151 |
0.97 |
chr7_37625778_37625969 | 15.90 |
Gm44883 |
predicted gene 44883 |
36765 |
0.15 |
chr7_4130711_4131434 | 15.45 |
Ttyh1 |
tweety family member 1 |
65 |
0.94 |
chr14_5501056_5501435 | 15.40 |
Gm3488 |
predicted gene, 3488 |
429 |
0.73 |
chr3_8511467_8511691 | 15.24 |
Stmn2 |
stathmin-like 2 |
1993 |
0.36 |
chr14_5148601_5148795 | 15.13 |
Gm3317 |
predicted gene 3317 |
15837 |
0.11 |
chr14_3651630_3651809 | 15.10 |
Gm3020 |
predicted gene 3020 |
311 |
0.84 |
chr14_6287027_6287952 | 14.86 |
Gm3411 |
predicted gene 3411 |
239 |
0.89 |
chr1_119049949_119050658 | 14.11 |
Gli2 |
GLI-Kruppel family member GLI2 |
3036 |
0.28 |
chr14_4854937_4855331 | 14.09 |
Gm3264 |
predicted gene 3264 |
442 |
0.76 |
chr14_64595318_64595919 | 14.08 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr7_25006131_25006556 | 13.98 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
385 |
0.75 |
chr2_127521161_127522051 | 13.87 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr14_3331997_3332403 | 13.86 |
Gm2956 |
predicted gene 2956 |
427 |
0.78 |
chr14_7174792_7175177 | 13.80 |
Gm3512 |
predicted gene 3512 |
451 |
0.77 |
chr14_4334095_4335404 | 13.54 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
14 |
0.97 |
chr14_4181957_4182899 | 13.40 |
Gm2974 |
predicted gene 2974 |
148 |
0.94 |
chr6_107529484_107530270 | 13.25 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
109 |
0.97 |
chr6_55452389_55452881 | 13.18 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
458 |
0.84 |
chr9_106464770_106466154 | 13.11 |
Gpr62 |
G protein-coupled receptor 62 |
476 |
0.6 |
chr14_3412209_3412992 | 13.06 |
Gm10409 |
predicted gene 10409 |
14 |
0.96 |
chr8_70315603_70316677 | 13.03 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr9_41375999_41376652 | 12.95 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr14_6427330_6427709 | 12.87 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
15037 |
0.14 |
chr1_34666183_34666826 | 12.82 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
11684 |
0.13 |
chr19_48205295_48205741 | 12.72 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
507 |
0.84 |
chr14_5388691_5389629 | 12.56 |
Gm3500 |
predicted gene 3500 |
111 |
0.95 |
chr11_69800687_69801257 | 12.54 |
Fgf11 |
fibroblast growth factor 11 |
744 |
0.33 |
chr10_78747019_78747870 | 12.46 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr12_29547825_29548188 | 12.26 |
Myt1l |
myelin transcription factor 1-like |
12784 |
0.23 |
chr14_5741218_5741986 | 12.22 |
Gm3373 |
predicted gene 3373 |
25 |
0.96 |
chr2_51087381_51087538 | 12.15 |
Rnd3 |
Rho family GTPase 3 |
61635 |
0.13 |
chr3_88205532_88206477 | 12.15 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr13_42709847_42710338 | 11.75 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr13_99443818_99444236 | 11.73 |
Map1b |
microtubule-associated protein 1B |
83 |
0.97 |
chr2_32742329_32742747 | 11.64 |
Sh2d3c |
SH2 domain containing 3C |
1046 |
0.25 |
chr14_5880011_5880704 | 11.63 |
Gm8237 |
predicted gene 8237 |
25 |
0.96 |
chr14_6604590_6605335 | 11.61 |
Gm3629 |
predicted gene 3629 |
14349 |
0.15 |
chr14_4498574_4499972 | 11.57 |
Gm3173 |
predicted gene 3173 |
15485 |
0.11 |
chr14_4726126_4727100 | 11.56 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr8_4212633_4214018 | 11.49 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr14_55029006_55029605 | 11.47 |
Ngdn |
neuroguidin, EIF4E binding protein |
7883 |
0.07 |
chr4_82690701_82691000 | 11.46 |
Gm11269 |
predicted gene 11269 |
1955 |
0.35 |
chr3_94477953_94478530 | 11.41 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr14_7027128_7027881 | 11.37 |
Gm10406 |
predicted gene 10406 |
55 |
0.96 |
chr9_102689518_102690683 | 11.30 |
4930533D04Rik |
RIKEN cDNA 4930533D04 gene |
2785 |
0.18 |
chr14_5070417_5071423 | 11.27 |
Gm8281 |
predicted gene, 8281 |
120 |
0.95 |
chr14_7658268_7659211 | 11.23 |
Gm10128 |
predicted gene 10128 |
14767 |
0.16 |
chr9_69670525_69670700 | 10.93 |
Gm47203 |
predicted gene, 47203 |
70858 |
0.09 |
chr18_42741001_42741152 | 10.84 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
118617 |
0.05 |
chr3_89391710_89392572 | 10.67 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
72 |
0.62 |
chr4_120716114_120716580 | 10.40 |
Kcnq4 |
potassium voltage-gated channel, subfamily Q, member 4 |
30901 |
0.11 |
chr4_3051990_3053232 | 10.34 |
Gm27878 |
predicted gene, 27878 |
792 |
0.7 |
chr10_69720220_69720528 | 10.31 |
Ank3 |
ankyrin 3, epithelial |
13896 |
0.29 |
chr8_94567491_94567722 | 10.25 |
Cpne2 |
copine II |
4956 |
0.14 |
chr14_64589182_64589588 | 10.19 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr10_58227289_58228680 | 10.15 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr14_62585498_62585685 | 10.13 |
Gm4131 |
predicted gene 4131 |
18670 |
0.12 |
chr10_81383963_81384933 | 10.11 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr1_191224278_191225037 | 10.10 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
183 |
0.92 |
chr14_4414844_4415804 | 10.05 |
Gm3164 |
predicted gene 3164 |
124 |
0.94 |
chr14_111675091_111675250 | 9.97 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
73 |
0.98 |
chr13_34129793_34130880 | 9.93 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr15_11904397_11905392 | 9.92 |
Npr3 |
natriuretic peptide receptor 3 |
745 |
0.59 |
chr14_6889264_6890534 | 9.83 |
Gm3667 |
predicted gene 3667 |
63 |
0.97 |
chr4_141048548_141049235 | 9.81 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
4770 |
0.13 |
chr4_106815721_106815901 | 9.77 |
Acot11 |
acyl-CoA thioesterase 11 |
10813 |
0.16 |
chr14_7105202_7106057 | 9.72 |
Gm3696 |
predicted gene 3696 |
5008 |
0.15 |
chr17_35836572_35837313 | 9.68 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr14_3809454_3810456 | 9.67 |
Gm3002 |
predicted gene 3002 |
119 |
0.95 |
chr7_51748719_51749329 | 9.67 |
Gm7336 |
predicted gene 7336 |
2377 |
0.28 |
chr18_35965723_35965937 | 9.55 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
725 |
0.59 |
chr2_17670178_17670376 | 9.50 |
Nebl |
nebulette |
60766 |
0.13 |
chr2_106425459_106425618 | 9.50 |
Dcdc5 |
doublecortin domain containing 5 |
41851 |
0.18 |
chr10_43174435_43174840 | 9.41 |
9030612E09Rik |
RIKEN cDNA 9030612E09 gene |
62 |
0.55 |
chr6_113857267_113857586 | 9.38 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
33944 |
0.13 |
chr1_12850975_12851126 | 9.37 |
Sulf1 |
sulfatase 1 |
8259 |
0.26 |
chr6_13835668_13836046 | 9.36 |
Gpr85 |
G protein-coupled receptor 85 |
1384 |
0.45 |
chr11_32001085_32001393 | 9.31 |
Nsg2 |
neuron specific gene family member 2 |
737 |
0.7 |
chr10_81059624_81060601 | 9.29 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
3 |
0.94 |
chr1_172350121_172350973 | 9.24 |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
9337 |
0.11 |
chr5_143270181_143270524 | 9.20 |
BC030343 |
cDNA sequence BC030343 |
277 |
0.51 |
chr8_3493298_3493991 | 9.12 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chr3_95161949_95162232 | 9.08 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
1585 |
0.17 |
chr3_10685256_10685662 | 9.07 |
Gm37831 |
predicted gene, 37831 |
39143 |
0.17 |
chr7_126949283_126949813 | 9.07 |
Asphd1 |
aspartate beta-hydroxylase domain containing 1 |
33 |
0.9 |
chr13_76825112_76825289 | 9.06 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
7 |
0.99 |
chr11_72041836_72042510 | 9.05 |
Pimreg |
PICALM interacting mitotic regulator |
141 |
0.94 |
chr18_23040919_23041185 | 9.04 |
Nol4 |
nucleolar protein 4 |
601 |
0.84 |
chr9_110053315_110053992 | 9.04 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr5_115435973_115436427 | 9.01 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
406 |
0.55 |
chr19_4711655_4711852 | 8.98 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
586 |
0.61 |
chr11_96872828_96873000 | 8.96 |
Gm11523 |
predicted gene 11523 |
1020 |
0.32 |
chr15_30457525_30457710 | 8.93 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
56 |
0.98 |
chr9_40268412_40269319 | 8.91 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr1_90202220_90202928 | 8.87 |
Ackr3 |
atypical chemokine receptor 3 |
1406 |
0.39 |
chrX_152368449_152368873 | 8.87 |
Gpr173 |
G-protein coupled receptor 173 |
43 |
0.55 |
chr13_74010757_74011079 | 8.87 |
Tppp |
tubulin polymerization promoting protein |
1499 |
0.22 |
chr4_136835920_136836937 | 8.84 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chrX_150657314_150657521 | 8.83 |
Tro |
trophinin |
18 |
0.97 |
chr11_80316377_80316533 | 8.82 |
Rhbdl3 |
rhomboid like 3 |
3235 |
0.24 |
chr5_128599236_128600028 | 8.78 |
Fzd10os |
frizzled class receptor 10, opposite strand |
1022 |
0.34 |
chr4_22488420_22489023 | 8.78 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr13_58808036_58808237 | 8.76 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
145 |
0.93 |
chr6_8956269_8957017 | 8.74 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr11_88462912_88463250 | 8.73 |
Gm11510 |
predicted gene 11510 |
29567 |
0.19 |
chr10_81472309_81472908 | 8.70 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr14_14349604_14349813 | 8.66 |
Il3ra |
interleukin 3 receptor, alpha chain |
87 |
0.94 |
chr11_85917416_85917567 | 8.65 |
Tbx4 |
T-box 4 |
20726 |
0.16 |
chr11_54304287_54304643 | 8.64 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
263 |
0.89 |
chr8_125569269_125570645 | 8.63 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr11_107793325_107793499 | 8.63 |
Gm11650 |
predicted gene 11650 |
454 |
0.72 |
chr15_78835129_78836581 | 8.62 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr2_174252117_174252268 | 8.62 |
Gm27591 |
predicted gene, 27591 |
4264 |
0.15 |
chr19_21781727_21782179 | 8.59 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
3565 |
0.26 |
chr13_83744885_83745867 | 8.57 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr2_53437127_53437348 | 8.56 |
Gm13501 |
predicted gene 13501 |
38750 |
0.2 |
chr9_20726843_20728134 | 8.55 |
Olfm2 |
olfactomedin 2 |
551 |
0.72 |
chr11_119156211_119156488 | 8.55 |
Mir6934 |
microRNA 6934 |
2212 |
0.22 |
chr17_55985980_55986972 | 8.54 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
33 |
0.94 |
chr5_116591724_116592384 | 8.52 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr1_167013567_167013899 | 8.48 |
Fam78b |
family with sequence similarity 78, member B |
12144 |
0.19 |
chr4_62582559_62582736 | 8.47 |
Rgs3 |
regulator of G-protein signaling 3 |
954 |
0.52 |
chr13_94575931_94576376 | 8.46 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
33850 |
0.14 |
chr3_88214175_88214875 | 8.41 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr8_48204156_48204432 | 8.39 |
Gm32842 |
predicted gene, 32842 |
66691 |
0.11 |
chr15_59040434_59041094 | 8.38 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr9_41273426_41274083 | 8.38 |
Gm48710 |
predicted gene, 48710 |
44872 |
0.11 |
chr7_79505823_79506244 | 8.38 |
Mir9-3 |
microRNA 9-3 |
769 |
0.43 |
chr9_107435027_107435183 | 8.37 |
Gm17141 |
predicted gene 17141 |
4538 |
0.13 |
chr5_66918045_66918260 | 8.37 |
Gm43281 |
predicted gene 43281 |
2144 |
0.26 |
chr5_37028527_37029187 | 8.34 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr2_11391722_11392142 | 8.32 |
8030442B05Rik |
RIKEN cDNA 8030442B05 gene |
6569 |
0.1 |
chr1_42693315_42693672 | 8.32 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr7_43489442_43490064 | 8.30 |
Iglon5 |
IgLON family member 5 |
322 |
0.72 |
chr7_63445176_63445439 | 8.29 |
Otud7a |
OTU domain containing 7A |
530 |
0.59 |
chr14_6756349_6757421 | 8.28 |
Gm3636 |
predicted gene 3636 |
14553 |
0.14 |
chr14_54912471_54913268 | 8.27 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
21 |
0.93 |
chr12_3364588_3366025 | 8.25 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr8_122284023_122284944 | 8.24 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr10_13117108_13117586 | 8.20 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
983 |
0.59 |
chr2_85198668_85199051 | 8.20 |
Lrrc55 |
leucine rich repeat containing 55 |
1662 |
0.23 |
chr2_130397163_130397956 | 8.16 |
Cpxm1 |
carboxypeptidase X 1 (M14 family) |
15 |
0.94 |
chr17_13759899_13761731 | 8.12 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr10_52742516_52742678 | 8.11 |
Gm47624 |
predicted gene, 47624 |
48759 |
0.11 |
chr3_108085301_108086522 | 8.11 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr14_3571400_3572424 | 8.11 |
Gm3005 |
predicted gene 3005 |
111 |
0.96 |
chr5_24606667_24606818 | 8.09 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
4730 |
0.11 |
chr16_20589916_20590682 | 8.08 |
Vwa5b2 |
von Willebrand factor A domain containing 5B2 |
86 |
0.78 |
chr2_30604975_30605527 | 8.05 |
Cstad |
CSA-conditional, T cell activation-dependent protein |
34 |
0.97 |
chr10_24228442_24228593 | 8.03 |
Moxd1 |
monooxygenase, DBH-like 1 |
4972 |
0.22 |
chr1_47277870_47278223 | 7.99 |
Gm4852 |
predicted pseudogene 4852 |
88326 |
0.09 |
chr3_101237534_101237701 | 7.89 |
Tpt1-ps1 |
tumor protein, translationally-controlled, pseudogene 1 |
4157 |
0.18 |
chr3_88208529_88208713 | 7.89 |
Gm3764 |
predicted gene 3764 |
851 |
0.35 |
chr7_45787153_45787575 | 7.87 |
Lmtk3 |
lemur tyrosine kinase 3 |
384 |
0.66 |
chr5_77358327_77358734 | 7.86 |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
18162 |
0.13 |
chr6_22984216_22984575 | 7.82 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr14_7314343_7315443 | 7.79 |
Gm3739 |
predicted gene 3739 |
156 |
0.94 |
chr9_37114956_37115270 | 7.76 |
Gm48716 |
predicted gene, 48716 |
3543 |
0.18 |
chr18_30509304_30509455 | 7.75 |
Gm7936 |
predicted pseudogene 7936 |
14006 |
0.19 |
chr10_60105916_60107197 | 7.74 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
88 |
0.97 |
chr19_41109550_41109792 | 7.73 |
Opalin |
oligodendrocytic myelin paranodal and inner loop protein |
32558 |
0.18 |
chr7_19118025_19118835 | 7.65 |
Gm4969 |
predicted gene 4969 |
62 |
0.92 |
chr14_19585224_19585528 | 7.65 |
Gm2237 |
predicted gene 2237 |
241 |
0.87 |
chr15_66285775_66286370 | 7.64 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
21 |
0.95 |
chr17_82857828_82858048 | 7.64 |
Gm4601 |
predicted gene 4601 |
98058 |
0.08 |
chr14_39472717_39472908 | 7.64 |
Nrg3 |
neuregulin 3 |
13 |
0.99 |
chr1_61139736_61139899 | 7.60 |
Gm11590 |
predicted gene 11590 |
15813 |
0.2 |
chr15_102510366_102511154 | 7.60 |
Map3k12 |
mitogen-activated protein kinase kinase kinase 12 |
32 |
0.95 |
chr2_180889406_180890514 | 7.59 |
Gm14342 |
predicted gene 14342 |
300 |
0.8 |
chr8_83876019_83876207 | 7.58 |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
23992 |
0.11 |
chr8_94999902_95000303 | 7.57 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
779 |
0.51 |
chr13_99516101_99516361 | 7.53 |
Map1b |
microtubule-associated protein 1B |
287 |
0.59 |
chr3_133754285_133754838 | 7.53 |
Gm6135 |
prediticted gene 6135 |
36943 |
0.17 |
chr1_172318498_172319013 | 7.50 |
Igsf8 |
immunoglobulin superfamily, member 8 |
5 |
0.95 |
chr1_172057571_172057962 | 7.47 |
Nhlh1 |
nescient helix loop helix 1 |
193 |
0.9 |
chr2_6483438_6484024 | 7.45 |
Gm38386 |
predicted gene, 38386 |
4041 |
0.22 |
chr5_46150385_46150536 | 7.44 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
218051 |
0.02 |
chr14_75455687_75456060 | 7.40 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr14_76254562_76255004 | 7.40 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
3326 |
0.28 |
chr3_34642143_34642294 | 7.39 |
Gm42692 |
predicted gene 42692 |
1046 |
0.36 |
chr9_91378183_91378872 | 7.39 |
Zic4 |
zinc finger protein of the cerebellum 4 |
115 |
0.94 |
chr9_56795792_56796100 | 7.37 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
192 |
0.93 |
chr3_89245365_89246153 | 7.37 |
Trim46 |
tripartite motif-containing 46 |
113 |
0.6 |
chr13_12650037_12651101 | 7.35 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr14_46647395_46647602 | 7.35 |
4933425B07Rik |
RIKEN cDNA 4933425B07 gene |
10075 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.6 | 13.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.5 | 13.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.5 | 26.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
4.4 | 13.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
4.0 | 16.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
3.9 | 23.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.8 | 11.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.3 | 26.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.3 | 9.8 | GO:0021564 | vagus nerve development(GO:0021564) |
3.3 | 6.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.2 | 9.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.1 | 21.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.1 | 9.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.0 | 9.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.9 | 32.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.9 | 26.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.9 | 5.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.9 | 8.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.9 | 8.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.9 | 2.9 | GO:0021586 | pons maturation(GO:0021586) |
2.8 | 5.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
2.8 | 8.5 | GO:0060166 | olfactory pit development(GO:0060166) |
2.8 | 11.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.8 | 19.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.8 | 2.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.7 | 10.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.7 | 8.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.7 | 13.5 | GO:0022038 | corpus callosum development(GO:0022038) |
2.7 | 18.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.7 | 2.7 | GO:0035787 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.7 | 8.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.6 | 2.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.6 | 10.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.6 | 7.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.5 | 7.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.5 | 9.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.4 | 22.0 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
2.4 | 12.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.4 | 7.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.4 | 7.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.4 | 4.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.4 | 7.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.4 | 9.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.3 | 9.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.3 | 13.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
2.2 | 4.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.2 | 4.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.2 | 2.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
2.1 | 4.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.1 | 6.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.1 | 6.4 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.1 | 8.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.1 | 8.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.1 | 6.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 8.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.1 | 8.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.0 | 6.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.0 | 2.0 | GO:0007412 | axon target recognition(GO:0007412) |
2.0 | 6.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
2.0 | 4.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.0 | 4.0 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
2.0 | 23.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.0 | 3.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.0 | 5.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
2.0 | 5.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.9 | 25.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.9 | 23.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.9 | 3.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.9 | 9.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.9 | 15.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.8 | 31.3 | GO:0008038 | neuron recognition(GO:0008038) |
1.8 | 9.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.8 | 1.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.8 | 5.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.8 | 5.4 | GO:0061511 | centriole elongation(GO:0061511) |
1.8 | 3.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.8 | 5.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.8 | 7.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.8 | 10.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.7 | 6.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.7 | 6.8 | GO:0051794 | regulation of catagen(GO:0051794) |
1.7 | 5.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.7 | 6.7 | GO:0001927 | exocyst assembly(GO:0001927) |
1.7 | 5.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.7 | 5.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.6 | 8.2 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.6 | 9.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.6 | 3.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.6 | 4.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.6 | 8.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.6 | 14.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.6 | 1.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.6 | 1.6 | GO:0090427 | activation of meiosis(GO:0090427) |
1.6 | 32.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.6 | 1.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.6 | 1.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.6 | 1.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.6 | 4.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.5 | 4.6 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.5 | 13.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.5 | 1.5 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.5 | 7.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.5 | 9.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.5 | 3.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.5 | 3.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.5 | 14.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.5 | 5.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.5 | 23.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.4 | 4.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.4 | 4.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.4 | 5.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.4 | 5.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 1.4 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.4 | 4.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.4 | 5.7 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.4 | 28.6 | GO:0001964 | startle response(GO:0001964) |
1.4 | 5.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.4 | 1.4 | GO:0060594 | mammary gland specification(GO:0060594) |
1.4 | 22.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.4 | 4.1 | GO:0030070 | insulin processing(GO:0030070) |
1.4 | 2.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.4 | 2.7 | GO:0035106 | operant conditioning(GO:0035106) |
1.4 | 2.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.4 | 4.1 | GO:0060459 | left lung development(GO:0060459) |
1.3 | 9.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.3 | 14.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.3 | 4.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.3 | 69.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.3 | 7.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.3 | 2.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.3 | 1.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.3 | 3.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.3 | 6.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.3 | 3.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.3 | 5.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.3 | 3.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.3 | 1.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.2 | 5.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 2.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.2 | 7.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
1.2 | 1.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 5.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.2 | 7.4 | GO:0015884 | folic acid transport(GO:0015884) |
1.2 | 4.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.2 | 14.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 3.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.2 | 2.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.2 | 6.1 | GO:0098597 | observational learning(GO:0098597) |
1.2 | 2.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.2 | 3.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 3.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.2 | 6.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.2 | 4.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.2 | 2.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.2 | 7.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 | 4.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 4.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.1 | 2.3 | GO:0008355 | olfactory learning(GO:0008355) |
1.1 | 14.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.1 | 3.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 3.3 | GO:0030421 | defecation(GO:0030421) |
1.1 | 4.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.1 | 11.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
1.1 | 8.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.1 | 2.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 5.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.1 | 1.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
1.1 | 5.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.1 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.0 | 1.0 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.0 | 3.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 4.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.0 | 4.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.0 | 1.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.0 | 6.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 2.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 4.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 1.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.0 | 2.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 4.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.0 | 17.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 1.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.0 | 7.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.0 | 2.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 5.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.0 | 4.9 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.0 | 5.9 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.0 | 3.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 5.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.0 | 2.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.0 | 1.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 1.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.0 | 5.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.0 | 5.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.9 | 0.9 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.9 | 5.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.9 | 2.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 6.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.9 | 1.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.9 | 2.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 10.1 | GO:0036065 | fucosylation(GO:0036065) |
0.9 | 1.8 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 12.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 3.6 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.9 | 15.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.9 | 7.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 2.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.9 | 2.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 2.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.9 | 15.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.9 | 7.9 | GO:0060004 | reflex(GO:0060004) |
0.9 | 2.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.9 | 6.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.9 | 62.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 3.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.9 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 8.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.9 | 1.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.9 | 0.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.9 | 13.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.8 | 3.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.8 | 2.5 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.8 | 5.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.8 | 1.7 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.8 | 1.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 3.3 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.8 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 4.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 3.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.8 | 2.5 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 1.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.8 | 2.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 5.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.8 | 0.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.8 | 5.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.8 | 1.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 1.6 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.8 | 3.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.8 | 3.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 1.6 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.8 | 7.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.8 | 4.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 21.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.8 | 9.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.8 | 2.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 3.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.8 | 1.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.8 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 3.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.7 | 5.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 1.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 4.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.7 | 2.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 22.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.7 | 2.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.7 | 2.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.7 | 1.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.7 | 24.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.7 | 2.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.7 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 3.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.7 | 0.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.7 | 2.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 1.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.7 | 3.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.7 | 2.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.7 | 0.7 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.7 | 1.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.7 | 4.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.4 | GO:0070779 | L-glutamate import(GO:0051938) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 9.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.7 | 2.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 0.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 5.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 1.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.7 | 1.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 27.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.7 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.7 | 0.7 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.6 | 1.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.6 | 1.3 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 3.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 5.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.6 | 7.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.6 | 5.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.6 | 2.5 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.6 | 1.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.6 | 4.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 2.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 1.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 0.6 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.6 | 3.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.6 | 1.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 5.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.6 | 1.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 2.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 7.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.6 | 1.8 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.6 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.6 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.6 | 9.2 | GO:0090102 | cochlea development(GO:0090102) |
0.6 | 1.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 2.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 1.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.6 | 1.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 2.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.6 | 2.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 2.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.6 | 2.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.6 | 1.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.5 | 1.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.5 | 1.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 3.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 2.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 2.7 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.5 | 1.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 2.7 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.5 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 2.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 3.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 1.6 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 1.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.5 | 1.0 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.5 | 4.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.5 | 3.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 2.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.5 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 1.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 1.0 | GO:0014075 | response to amine(GO:0014075) |
0.5 | 0.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 1.5 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.5 | 2.5 | GO:0035989 | tendon development(GO:0035989) |
0.5 | 6.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 3.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 3.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 1.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 1.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.5 | 5.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 1.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 5.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 0.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 1.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 1.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 2.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 0.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 2.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.5 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 3.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 6.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 0.4 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.4 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 12.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 1.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.4 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 0.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 1.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 1.7 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 11.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 2.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.4 | 10.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 1.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 1.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 1.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.4 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 6.3 | GO:0003016 | respiratory system process(GO:0003016) |
0.4 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 2.6 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.4 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 1.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 2.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 1.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 5.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 1.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 0.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 2.5 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 0.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.0 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 2.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 3.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 1.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 5.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 1.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 1.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.3 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.3 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.3 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.9 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 2.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 2.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 2.7 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 0.6 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.3 | 0.9 | GO:0021548 | pons development(GO:0021548) |
0.3 | 1.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 3.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.3 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) |
0.3 | 0.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 4.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.3 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.3 | 1.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 2.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.3 | 0.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 0.8 | GO:0015846 | polyamine transport(GO:0015846) |
0.3 | 0.8 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 2.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 2.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.3 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.3 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 2.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 0.5 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.3 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 1.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 3.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 1.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 2.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 2.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 1.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.5 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 1.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 5.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 2.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 5.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 2.9 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 1.9 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 1.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.6 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 2.6 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 1.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 2.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 16.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.2 | 1.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.4 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 1.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 2.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 1.2 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.8 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.2 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.5 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 0.6 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.2 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.8 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 2.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 1.6 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.6 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 2.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.6 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 1.4 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 9.7 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.4 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.1 | GO:0010970 | establishment of localization by movement along microtubule(GO:0010970) |
0.1 | 0.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.1 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 2.9 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 1.0 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.5 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.0 | 0.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.3 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.0 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.0 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 15.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.0 | 3.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.7 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.4 | 7.2 | GO:0072534 | perineuronal net(GO:0072534) |
2.4 | 16.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.3 | 2.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.2 | 17.9 | GO:0043083 | synaptic cleft(GO:0043083) |
2.2 | 6.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.1 | 58.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.1 | 6.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.1 | 8.3 | GO:0045298 | tubulin complex(GO:0045298) |
1.9 | 34.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.9 | 11.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.8 | 16.5 | GO:0043194 | axon initial segment(GO:0043194) |
1.8 | 16.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 9.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.7 | 10.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.7 | 20.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 5.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.7 | 8.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.6 | 4.9 | GO:0097441 | basilar dendrite(GO:0097441) |
1.6 | 4.9 | GO:0048179 | activin receptor complex(GO:0048179) |
1.6 | 6.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.5 | 6.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.5 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
1.5 | 11.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 32.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.5 | 20.3 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 11.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.3 | 6.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.2 | 13.4 | GO:0001527 | microfibril(GO:0001527) |
1.2 | 4.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.2 | 1.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.2 | 7.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 4.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.2 | 4.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 8.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.1 | 26.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.0 | 1.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 4.1 | GO:0032021 | NELF complex(GO:0032021) |
1.0 | 14.1 | GO:0043196 | varicosity(GO:0043196) |
1.0 | 12.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 2.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 2.9 | GO:0032280 | symmetric synapse(GO:0032280) |
1.0 | 2.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 53.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 13.3 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 2.8 | GO:0044308 | axonal spine(GO:0044308) |
0.9 | 8.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 2.7 | GO:0097433 | dense body(GO:0097433) |
0.9 | 5.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 2.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 9.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 3.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.8 | 2.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 2.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.8 | 10.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 6.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 3.0 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 98.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.7 | 20.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 23.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.7 | 2.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 1.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 3.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 3.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 1.8 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 3.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.6 | 2.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.6 | 2.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 5.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 1.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 70.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 15.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 1.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 2.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 4.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 2.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 1.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 4.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 40.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 3.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 3.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 3.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 1.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 3.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 1.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 1.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 2.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 4.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 1.9 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 20.6 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 4.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 3.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 3.5 | GO:0043679 | axon terminus(GO:0043679) |
0.3 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 6.4 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.0 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 4.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 3.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 6.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 13.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 2.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 2.3 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.6 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.3 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 6.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 1.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.9 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 5.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 2.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 31.2 | GO:0045202 | synapse(GO:0045202) |
0.1 | 6.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 2.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.3 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 14.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 1.3 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.2 | 18.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
5.4 | 16.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
5.4 | 21.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
5.3 | 15.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
4.7 | 18.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
4.4 | 22.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.3 | 12.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.1 | 16.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.0 | 16.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
4.0 | 51.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
3.8 | 22.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.4 | 10.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.4 | 10.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.1 | 18.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.7 | 8.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.6 | 7.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.5 | 10.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.5 | 7.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.5 | 9.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.4 | 12.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.4 | 11.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.2 | 6.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.2 | 15.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.1 | 6.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.1 | 6.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.0 | 8.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.0 | 6.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.9 | 13.6 | GO:0003680 | AT DNA binding(GO:0003680) |
1.9 | 7.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.9 | 16.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.8 | 7.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.8 | 34.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.8 | 9.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 9.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.7 | 13.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.7 | 15.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.7 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
1.7 | 6.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.6 | 4.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.6 | 10.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.5 | 3.1 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 17.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.5 | 6.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.5 | 6.0 | GO:0038100 | nodal binding(GO:0038100) |
1.5 | 7.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.5 | 3.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.5 | 4.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.4 | 5.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.3 | 10.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 4.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.3 | 31.4 | GO:0030552 | cAMP binding(GO:0030552) |
1.3 | 13.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.3 | 3.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 7.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.2 | 8.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.2 | 6.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.2 | 11.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 5.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.1 | 2.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.1 | 3.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 32.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 19.4 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 5.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.1 | 5.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 4.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.0 | 3.1 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 11.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.0 | 20.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 2.0 | GO:0070905 | serine binding(GO:0070905) |
1.0 | 9.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 24.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.0 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 7.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 11.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.0 | 3.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.0 | 6.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.0 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.0 | 5.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.0 | 2.9 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.0 | 13.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.9 | 5.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 6.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 4.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 2.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.9 | 10.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 2.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 1.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.9 | 0.9 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.9 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 2.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 3.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 1.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.8 | 24.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 4.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 2.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.8 | 3.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 3.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 3.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 6.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 10.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 3.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.8 | 31.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.8 | 3.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.8 | 3.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 3.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.7 | 3.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 3.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 19.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.7 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 2.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.7 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 3.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 4.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 0.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.7 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 16.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.6 | 4.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 3.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 1.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 2.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 1.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 8.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 11.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 7.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.6 | 3.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.6 | 3.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 7.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 3.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 6.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 0.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 1.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 1.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 1.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 10.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 3.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.4 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 5.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 2.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 2.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 4.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.5 | 15.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 4.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 6.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.4 | 3.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 2.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 11.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 1.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 5.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 3.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.4 | 9.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 2.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.4 | 9.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 0.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 8.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 7.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 5.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 4.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 7.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 4.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 2.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 4.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 3.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 1.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 2.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 2.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 2.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 4.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 3.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 11.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 3.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 27.7 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 2.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 3.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 3.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 4.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 2.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.0 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 5.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.2 | 2.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.0 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 2.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 6.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 2.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 2.0 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.5 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 2.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 5.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 1.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 7.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 5.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 3.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 2.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 1.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 1.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 5.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 50.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 7.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 1.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.3 | GO:0052635 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 15.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 4.8 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.5 | 47.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 10.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.1 | 26.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.8 | 12.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 5.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.7 | 2.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.7 | 12.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 9.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 19.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 8.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 10.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 4.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 87.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 14.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 3.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 4.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 2.9 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 3.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 9.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 6.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 6.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 10.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 3.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 9.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 8.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 6.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 9.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 3.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 6.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
2.3 | 28.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.0 | 2.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.6 | 22.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.6 | 33.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 3.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.5 | 21.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 29.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 21.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.2 | 49.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 16.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.0 | 11.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 24.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 8.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.9 | 2.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.9 | 25.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.8 | 13.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.8 | 10.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.8 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 19.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 8.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 30.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.8 | 10.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 8.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.7 | 3.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.6 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.6 | 18.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 5.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 3.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 4.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.5 | 7.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 8.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 6.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 10.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 1.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 10.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.5 | 1.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 6.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 27.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.4 | 3.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 9.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 2.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 1.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 4.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 3.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 2.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 3.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 6.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 0.5 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.3 | 2.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 5.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 6.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.9 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 7.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 3.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 3.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 3.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 10.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |